Home/Pipeline/Gastromotal

Gastromotal

Gastric Emptying Assessment

Pre-approvalActive

Key Facts

Indication
Gastric Emptying Assessment
Phase
Pre-approval
Status
Active
Company

About INFAI

INFAI is a pioneer in non-invasive diagnostic tests using stable isotope technology, with a core focus on gastroenterology, metabolic, and cardiovascular diseases. The company's lead product, the Helicobacter Test INFAI, is an EMA-approved breath test registered in over 40 countries, establishing a commercial foundation. INFAI operates a Virtually Integrated Pharmaceutical Company (VIPCO) model with a lean internal team, supported by two advanced laboratories in Germany and the UK used for internal R&D and contract research. Its pipeline includes additional breath tests for gastric emptying and pancreatic function currently in preparation for regulatory approval.

View full company profile